PF-06445974,98.23%

产品编号:Bellancom-119190| CAS NO:2055776-17-3| 分子式:C20H15FN4O| 分子量:346.36

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-119190
2500.00 杭州 北京(现货)
Bellancom-119190
4000.00 杭州 北京(现货)
Bellancom-119190
8500.00 杭州 北京(现货)
Bellancom-119190
13500.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

PF-06445974

产品介绍 PF-06445974 是一种正电子发射断层扫描 (PET) 化合物,有效作用于 PDE4BIC50 <1 nM。对 PDE4D、PDE4A 和 PDE4C 的 IC50 值分别为 36、4.7 和 17 nM。PF-06445974对 PDE4D 具有良好的选择性,出色的脑通透性,在 “冷示踪剂” 研究中能够高水平特异性结合。
生物活性

PF-06445974, a promising positron emission tomography (PET) lead, has exquisite potency at PDE4B with an IC50 <1 nM. The IC50 values are 36, 4.7 and 17 nM for PDE4D, PDE4A and PDE4C, respectively. PF-06445974 has good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study.

体外研究

PF-06445974 demonstrates minimal off-target activities in broad-spectrum selectivity panels, with only weak µM activities at PDE10 (IC50=2290 nM), PDE5A (IC50=4640 nM) and GABAA (Ki=3850 nM).

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

PF-06445974 exhibits high central nervous system (CNS) PET MPO score (4.0). PF-06445974 is a promising radiotracer lead for specific binding assessment. Neuropharmacokinetic study in rats (0.1 mg/kg, IV) confirms high brain permeability with a total brain to plasma ratio of 0.76, corresponding to a free brain to plasma ratio of 0.70.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Twenty-five drug-naive male 129/B6 PDE4D KO mice (25-35 g)
Dosage: 10 µg/kg
Administration: Dosed intravenously at 10 µg/kg in a 5 mL/kg dosing volume
Result: Showed excellent brain uptake and reached peak concentrations at around 20 minutes.
体内研究

PF-06445974 exhibits high central nervous system (CNS) PET MPO score (4.0). PF-06445974 is a promising radiotracer lead for specific binding assessment. Neuropharmacokinetic study in rats (0.1 mg/kg, IV) confirms high brain permeability with a total brain to plasma ratio of 0.76, corresponding to a free brain to plasma ratio of 0.70.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Twenty-five drug-naive male 129/B6 PDE4D KO mice (25-35 g)
Dosage: 10 µg/kg
Administration: Dosed intravenously at 10 µg/kg in a 5 mL/kg dosing volume
Result: Showed excellent brain uptake and reached peak concentrations at around 20 minutes.
性状Solid
溶解性数据
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服